Novel ppar-alpha/delta dual agonist ETI-039 to treat pulmonary fibrosis

Active Project Grant Awarded Last action

Award ID
W81XWH2010540
Recipient
Awarding agency
Obligated
$3,256,955

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 96% complete
Originally
Place of performance
San Diego, CA 92106, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Novel ppara/D dual agonist ETI-039 to treat pulmonary fibrosis extend the period of performance $0
Amendment Novel ppar a/D dual agonist ETI-039 to treat pulmonary fibrosis-extend period of performace. $0
Amendment Novel ppara/D dual agonist ETI-039 to treat pulmonary fibrosis extend the period of performance 1. Per section 711 of the national defense authorization act… $0
Original award $3,256,955

Quick answers

Who received award W81XWH2010540?

W81XWH2010540 was awarded to Epitracker, Inc. by Defense Health Agency (Department of Defense) on August 1, 2020.

How much is award W81XWH2010540 worth?

$3,256,955 has been obligated on W81XWH2010540.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login